Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ICMT inhibitors(isoprenylcysteine carboxyl methyltransferase inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H32N2O2 |
InChIKeyBLQZCBCZOHGCHD-UHFFFAOYSA-N |
CAS Registry1621536-10-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hutchinson-Gilford progeria syndrome | Preclinical | ES | 27 Jun 2021 |